Seer, Inc. (NASDAQ:SEER - Get Free Report) dropped 2.5% during mid-day trading on Thursday . The stock traded as low as $1.99 and last traded at $1.99. Approximately 168,768 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 345,725 shares. The stock had previously closed at $2.04.
Seer Stock Performance
The firm has a fifty day moving average of $1.95 and a 200 day moving average of $2.16. The firm has a market capitalization of $118.97 million, a PE ratio of -1.53 and a beta of 1.61.
Institutional Investors Weigh In On Seer
Hedge funds have recently bought and sold shares of the business. Y Intercept Hong Kong Ltd acquired a new stake in shares of Seer during the fourth quarter worth approximately $36,000. Corient Private Wealth LLC grew its holdings in Seer by 66.0% during the 4th quarter. Corient Private Wealth LLC now owns 33,200 shares of the company's stock worth $77,000 after acquiring an additional 13,200 shares in the last quarter. Schonfeld Strategic Advisors LLC bought a new stake in shares of Seer in the 4th quarter worth about $103,000. OMERS ADMINISTRATION Corp acquired a new stake in shares of Seer in the 4th quarter valued at about $114,000. Finally, Barclays PLC lifted its position in shares of Seer by 34.1% during the third quarter. Barclays PLC now owns 64,426 shares of the company's stock worth $127,000 after purchasing an additional 16,382 shares during the last quarter. Institutional investors and hedge funds own 75.20% of the company's stock.
Seer Company Profile
(
Get Free Report)
Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
See Also
Before you consider Seer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.
While Seer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
